<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.0.0 (http://www.squarespace.com/) on Tue, 06 Jan 2009 21:04:39 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>Psychiatric Comorbidities</title><link>http://brainscienceblogs.com/psychiatric-comorbidities/</link><description></description><copyright></copyright><language>en-US</language><generator>Squarespace Site Server v5.0.0 (http://www.squarespace.com/)</generator><item><title>Psychiatric Comorbidities</title><category>Psychiatric Comorbidities</category><dc:creator>Contacts</dc:creator><pubDate>Tue, 25 Mar 2008 21:53:12 +0000</pubDate><link>http://brainscienceblogs.com/psychiatric-comorbidities/2008/3/25/psychiatric-comorbidities.html</link><guid isPermaLink="false">140403:2122380:1714371</guid><description><![CDATA[<a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=15" target="_blank">Cholesterol-Lowering Medication and Relapse of Depression<br />By David C. Steffens,MD, MHS, Douglas R. McQuoid, BS, and K. Ranga Rama Krishnan, MB, ChB</a>
]]></description><wfw:commentRss>http://brainscienceblogs.com/psychiatric-comorbidities/rss-comments-entry-1714371.xml</wfw:commentRss></item></channel></rss>